191 related articles for article (PubMed ID: 25117898)
1. Circulating levels of chemokines in psoriasis.
Lima XT; Oliveira RT; Braga FG; Magalhães RF; Mamoni RL; Blotta MH
Autoimmunity; 2015 Feb; 48(1):57-60. PubMed ID: 25117898
[TBL] [Abstract][Full Text] [Related]
2. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
3. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives.
Chuang YH; Lian ZX; Cheng CM; Lan RY; Yang GX; Moritoki Y; Chiang BL; Ansari AA; Tsuneyama K; Coppel RL; Gershwin ME
J Autoimmun; 2005 Sep; 25(2):126-32. PubMed ID: 16243485
[TBL] [Abstract][Full Text] [Related]
5. Optic neuritis: chemokine receptor CXCR3 and its ligands.
Sørensen TL; Roed H; Sellebjerg F
Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
7. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
8. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
[TBL] [Abstract][Full Text] [Related]
9. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
[TBL] [Abstract][Full Text] [Related]
10. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
11. Th1 cytokines and chemokines in primary biliary cirrhosis.
Limongi F
Clin Ter; 2015; 166(2):e122-5. PubMed ID: 25945445
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11.
Lepej SZ; Rode OD; Jeren T; Vince A; Remenar A; Barsić B
J Neuroimmunol; 2005 Jun; 163(1-2):128-34. PubMed ID: 15885315
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
[TBL] [Abstract][Full Text] [Related]
14. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
15. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Lee SJ; Kang SE; Kang EH; Choi BY; Masek-Hammerman K; Syed J; Zhan Y; Neff-Phillips K; Park JK; Lee EY; Lee EB; Song YW
Sci Rep; 2017 Nov; 7(1):14720. PubMed ID: 29116188
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
19. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
